Home > Insider Trading > Filing (0001181431-12-007504)

Filing Details

Accession Number:: 0001181431-12-007504
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2012-02-09 18:54:47
Reporting Period:: 2012-02-07

Filing Date:: 2012-02-09
Accepted Time:: 2012-02-09 18:54:47
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1011835	Medivation Inc.	MDVN	Pharmaceutical Preparations (2834)	133863260

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1311210	Patrick Clarence Machado	C/O Medivation, Inc. 201 Spear Street, 3Rd Floor San Francisco CA 94105	Chief Business Officer And Cfo	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2012-02-07	16,391	$11.76	80,807	No	4	M	Indirect	By Trust
Common Stock	Disposition	2012-02-07	4,500	$70.32	76,307	No	4	S	Indirect	By Trust
Common Stock	Disposition	2012-02-07	15,997	$71.30	60,310	No	4	S	Indirect	By Trust
Common Stock	Disposition	2012-02-07	22,010	$72.20	38,300	No	4	S	Indirect	By Trust
Common Stock	Disposition	2012-02-07	400	$73.17	37,900	No	4	S	Indirect	By Trust
Common Stock	Acquisiton	2012-02-08	19,193	$11.76	57,093	No	4	M	Indirect	By Trust
Common Stock	Disposition	2012-02-08	19,900	$68.35	37,193	No	4	S	Indirect	By Trust
Common Stock	Disposition	2012-02-08	29,100	$69.16	8,093	No	4	S	Indirect	By Trust
Common Stock	Disposition	2012-02-08	5,900	$70.16	2,193	No	4	S	Indirect	By Trust
Common Stock	Disposition	2012-02-08	2,193	$71.25	0	No	4	S	Indirect	By Trust

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	M	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	M	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust
No	4	S	Indirect	By Trust

Reported Derivative Transactions

Show Other Fields >>

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2012-02-07	16,391	$0.00	16,391	$11.76
Common Stock	Stock Option (Right to Buy)	Disposition	2012-02-08	19,193	$0.00	19,193	$11.76

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
133,609		2016-10-31	No	4	M	Direct
114,416		2016-10-31	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	21,511	Direct

Footnotes

Shares sold pursuant to a 10b5-1 Plan.
The shares were sold at prices between $69.85 and $70.85. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $70.92 and $71.90. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $71.94 and $72.68. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $72.91 and $73.30. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $67.72 and $68.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $68.73 and $69.72. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $69.73 and $70.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices between $70.73 and $71.88. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Fully vested.